InhaleRx Limited (AU:IRX)
ASX:IRX
Australian Market
Holding AU:IRX?
Track your performance easily

InhaleRx Limited (IRX) Financial Statements

5 Followers

InhaleRx Limited Financial Overview

InhaleRx Limited's market cap is currently ―. The company's EPS TTM is AU$-0.004; its P/E ratio is -6.00; InhaleRx Limited is scheduled to report earnings on February 24, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19Dec 18
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 2.13MAU$ 2.80MAU$ 1.72MAU$ 424.92KAU$ 2.31M
Total AssetsAU$ 2.26MAU$ 2.93MAU$ 1.90MAU$ 623.71KAU$ 3.09M
Total DebtAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Net DebtAU$ -2.13MAU$ -2.80MAU$ -1.72MAU$ -424.92KAU$ -2.31M
Total LiabilitiesAU$ 330.09KAU$ 253.34KAU$ 580.10KAU$ 283.63KAU$ 408.33K
Stockholders EquityAU$ 1.93MAU$ 2.68MAU$ 1.32MAU$ 340.08KAU$ 2.68M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in AUD

InhaleRx Limited Earnings and Revenue History

InhaleRx Limited Debt to Assets

InhaleRx Limited Cash Flow

InhaleRx Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis